Why ungoverned AI tools are filling the gaps your workflow platform left behind.
Somewhere in your organization right now, someone is pasting a research proposal into ChatGPT.
They're not doing anything malicious. They're trying to get through a pile of IIS concept submissions before their next meeting. The documents are dense — 40-page PDFs covering study objectives, endpoints, investigator credentials, budget justifications, and timeline projections. Reading and summarizing each one takes an hour or more. The AI summary takes 30 seconds.This scene plays out daily across life sciences organizations. When workflow platforms don't offer AI capabilities, teams don't simply accept slower timelines. They find workarounds. They paste regulatory content into consumer chatbots. They use personal Copilot accounts to draft summaries. They run sensitive research concepts through tools that sit entirely outside organizational governance.
The work gets done faster. The audit trail disappears.
Life sciences operate under a fundamental assumption: decisions can be traced, verified, and defended. Regulatory submissions, clinical trial documentation, investigator-initiated study reviews — these processes exist within frameworks designed to ensure accountability at every step.
Shadow AI breaks this assumption quietly. When a coordinator uses ChatGPT to summarize an IIS proposal, there's no record of what the AI produced, no way to trace how extracted data points reached the final form, no visibility into whether the summary accurately represented the source material. If a reviewer makes a decision based on that summary, the decision tree now includes an invisible node.
This isn't a hypothetical risk. It's a structural gap created when regulated workflows meet consumer AI tools.
Two paths to AI-assisted processing. Only one maintains compliance.
Investigator-initiated study programs face a specific version of this pressure. External investigators submit research concept proposals in whatever format works for them — PDFs, Word documents, PowerPoint decks, sometimes all three for a single submission.
Each package needs to be read, understood, and translated into structured data before it can reach a scientific review committee.
The manual process looks something like this:
This process repeats for every submission. For organizations receiving dozens or hundreds of IIS concepts annually, the hours compound quickly.
It's exactly the kind of tedious, high-volume work where AI promises immediate relief. And when the official workflow platform doesn't offer that relief, coordinators find their own solutions.
The appeal of consumer AI tools is obvious: they're fast, accessible, and increasingly capable. The problem isn't the technology itself — it's the context in which it operates.
Governed AI in a regulated environment requires specific architectural decisions that consumer tools weren't designed to provide.
When AI generates a summary or extracts a data point, users need to verify that output against the original document. This means more than producing plausible text — it means linking every extracted element back to its source location. If the AI says the proposed study duration is 18 months, a reviewer should be able to click through to the exact page and paragraph where that figure appears.
Organizations need to know when AI was used, what it produced, and how that output influenced downstream decisions. This audit trail can't be optional or retroactively constructed. It needs to be built into the workflow from the start.
AI acceleration works best when it changes what humans do, not whether humans are involved. Auto-populated fields should surface for coordinator verification. Generated summaries should be reviewed before routing. The goal is to shift human effort from data extraction to data validation — a higher-value activity that still maintains accountability.
Sensitive research concepts, investigator information, and proprietary study designs shouldn't leave organizational boundaries to reach third-party AI services. The AI capability needs to operate within the same security and compliance perimeter as the rest of the workflow.
These requirements translate existing regulatory expectations into the context of AI-assisted work.
A comparison showing the gap between what consumer tools provide and what regulated workflows require.
|
Requirement
|
Consumer AI
|
Governed AI
|
| Source citations | ✘ Not available | ✔︎ Cites original document |
| Audit trail | ✘ No record | ✔︎ Every action logged |
| Human review gates | ✘ User discretion | ✔︎ Built into workflow |
| Data containment | ✘ Data sent externally | ✔︎ Stays within platform |
| Duplicate detection | ✘ No cross-reference | ✔︎ Flags duplicates |
| Compliance flagging | ✘ Generic output | ✔︎ Configured to SOPs |
When we built the research concept triage capability for Approvia IIS, these requirements shaped every design decision.
Early in development, we faced a fundamental question: should the AI simply produce a summary, or should it show its work? We chose the latter. Every summary Approvia generates includes source citations that link back to specific locations in the original document. When the system extracts an investigator's institutional affiliation or a study's primary endpoint, reviewers can verify that extraction against the source material.
This decision added complexity to the system. It also addressed one of the core anxieties around AI in regulated environments: the fear that AI-generated content will be trusted without verification. Source citations don't eliminate the need for human judgment — they make human judgment more efficient by eliminating the manual cross-referencing step.
We debated how much the system should do automatically. Should extracted data flow directly into system fields, or should it surface for coordinator review first? We landed on a middle path: Approvia AI extracts and maps data to fields, but coordinators see what was extracted and can correct errors before the data is committed.
This approach preserves the time savings of automated extraction while maintaining human accountability for data accuracy. It also creates a feedback loop — when coordinators correct AI extractions, those corrections can inform system improvements over time.
We built Approvia AI to distinguish between critical gaps (missing IRB status, unclear study duration, absent budget justification) and minor omissions, flagging each appropriately so coordinators and reviewers can prioritize their attention.
Catching these patterns manually requires institutional memory that may not exist in every coordinator.
Approvia AI scans incoming submissions against historical records, flagging potential duplicates before they consume review committee time.
IIS intake is one instance of a pattern that recurs across life sciences operations. Wherever teams face high-volume document processing with compliance requirements, the same dynamic emerges: manual processes create pressure, pressure creates workarounds, and workarounds create compliance gaps.
Document-heavyDense documents requiring reading, extraction, and summarization. |
Time pressureVolume and deadlines create pressure to find faster methods. |
Platform gapsWorkflow tools don’t offer AI capabilities, so teams find workarounds. |
Medical information teams receiving inquiries that need compliant responses. Regulatory affairs teams processing submission packages. Pharmacovigilance teams triaging adverse event reports. Publication teams managing manuscript workflows. Each domain has its own document types, its own compliance requirements, and its own version of the shadow AI temptation.
The question isn't whether teams will use AI — that decision has already been made, often informally and invisibly. The question is whether organizations will govern that AI use or discover it during an audit.
The same pattern repeats across life sciences functions. Different documents, same compliance gaps.
What's at risk? |
The alternative |
|
|
Organizations discovering shadow AI use typically respond reactively: new policies prohibiting external AI tools, additional training on data handling, stricter access controls. These measures address symptoms without solving the underlying problem.
The underlying problem is unmet need. When coordinators paste documents into ChatGPT, they're not rebelling against compliance requirements — they're trying to do their jobs faster. The behavior will persist as long as the need persists. A proactive approach starts with a different question: What would it take to offer AI capabilities that meet both the operational need and the compliance requirement?
This framing shifts the conversation from prohibition to provision. Instead of telling teams they can't use AI, organizations can offer AI that works within governed boundaries. Instead of creating adversarial dynamics between compliance and operations, organizations can align them around shared tools.
The investment required isn't trivial. Building or buying governed AI capabilities takes resources. Training teams to use new tools takes time. Integrating AI into existing workflows takes change management. But the alternative — an expanding gap between how work actually gets done and how it's supposed to get done — carries its own costs, measured in audit findings and compliance remediation.
Organizations evaluating AI capabilities for regulated workflows should examine several dimensions.
The question facing life sciences organizations isn't whether to adopt AI — adoption is already happening, one ChatGPT session at a time. The question is whether that adoption will be governed or ungoverned, visible or invisible, compliant or risky.
Governed AI in regulated workflows isn't about limiting what teams can do. It's about enabling what they're already trying to do, within boundaries that protect the organization and maintain the traceability that regulatory frameworks require.
For IIS programs, this means coordinators who can process submissions faster without sacrificing audit trail integrity. For Medical Affairs more broadly, it means closing the gap between operational pressure and compliance requirements — a gap that shadow AI fills poorly and governed AI fills well.
The organizations that navigate this transition successfully will be those that recognize AI adoption as an inevitability to be channeled, not a threat to be blocked.
Approvia brings governed AI to Medical Affairs teams. From research concept triage to plain language summary generation, Approvia’s capabilities are designed for regulated environments where traceability, human oversight, and compliance aren't optional.
Request a demo to see how Approvia handles your document types and workflow requirements.